Charles Elliott Sigal - Net Worth and Insider Trading
Charles Elliott Sigal Net Worth
The estimated net worth of Charles Elliott Sigal is at least $458,717 dollars as of 2024-11-10. Charles Elliott Sigal is the Director of Adaptimmune Therapeutics PLC and owns about 367,038 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $292,493. Charles Elliott Sigal is also the Director of Vir Biotechnology Inc and owns about 17,279 shares of Vir Biotechnology Inc (VIR) stock worth over $166,224. Details can be seen in Charles Elliott Sigal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Elliott Sigal has not made any transactions after 2023-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Elliott Sigal
Charles Elliott Sigal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Elliott Sigal owns 4 companies in total, including Vir Biotechnology Inc (VIR) , Adaptimmune Therapeutics PLC (ADAP) , and Surface Oncology Inc (SURF) among others .
Click here to see the complete history of Charles Elliott Sigal’s form 4 insider trades.
Insider Ownership Summary of Charles Elliott Sigal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VIR | Vir Biotechnology Inc | 2023-01-05 | director |
| ADAP | Adaptimmune Therapeutics PLC | 2016-05-19 | director |
| SURF | Surface Oncology Inc | 2018-07-02 | director |
 | | 2022-08-22 | director |
Charles Elliott Sigal Latest Holdings Summary
Charles Elliott Sigal currently owns a total of 2 stocks. Among these stocks, Charles Elliott Sigal owns 367,038 shares of Adaptimmune Therapeutics PLC (ADAP) as of May 19, 2016, with a value of $292,493 and a weighting of 63.76%. Charles Elliott Sigal also owns 17,279 shares of Vir Biotechnology Inc (VIR) as of January 5, 2023, with a value of $166,224 and a weighting of 36.24%.
Latest Holdings of Charles Elliott Sigal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2016-05-19 | 367,038 | 0.80 | 292,493 |
| VIR | Vir Biotechnology Inc | 2023-01-05 | 17,279 | 9.62 | 166,224 |
Holding Weightings of Charles Elliott Sigal
Charles Elliott Sigal Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Elliott Sigal has made a total of 0 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years. The most-recent trade in Adaptimmune Therapeutics PLC is the acquisition of 15,000 shares on May 19, 2016, which cost Charles Elliott Sigal around $23,400.
According to the SEC Form 4 filings, Charles Elliott Sigal has made a total of 2 transactions in Vir Biotechnology Inc (VIR) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vir Biotechnology Inc is the acquisition of 2,500 shares on January 5, 2023, which cost Charles Elliott Sigal around $62,400.
Insider Trading History of Charles Elliott Sigal
- 1
Charles Elliott Sigal Trading Performance
GuruFocus tracks the stock performance after each of Charles Elliott Sigal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Elliott Sigal is -16.57%. GuruFocus also compares Charles Elliott Sigal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Elliott Sigal within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Elliott Sigal's insider trading performs compared to the benchmark.
Performance of Charles Elliott Sigal
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.93 | | | | | |
| Relative Return to S&P 500(%) | 3.27 | | | | | |
Charles Elliott Sigal Ownership Network
Ownership Network List of Charles Elliott Sigal
Ownership Network Relation of Charles Elliott Sigal
Charles Elliott Sigal Owned Company Details
What does Vir Biotechnology Inc do?
Who are the key executives at Vir Biotechnology Inc?
Charles Elliott Sigal is the director of Vir Biotechnology Inc. Other key executives at Vir Biotechnology Inc include Chief Executive Officer Backer Marianne De , Chief Technology Officer Ann M. Hanly , and Chief Financial Officer Sung Lee .
Vir Biotechnology Inc (VIR) Insider Trades Summary
Over the past 18 months, Charles Elliott Sigal made no insider transaction in Vir Biotechnology Inc (VIR). Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 952,542 shares made by Svf Endurance (cayman) Ltd , a net sale of 22,889 shares made by Phillip Pang , and a net sale of 55,500 shares made by George A Scangos .
In summary, during the past 3 months, insiders sold 20,337 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 20,337 shares. During the past 18 months, 1,173,278 shares of Vir Biotechnology Inc (VIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,173,278 shares.
Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vir Biotechnology Inc Insider Transactions
Charles Elliott Sigal Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Elliott Sigal. You might contact Charles Elliott Sigal via mailing address: 32 Brearly Road, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
